Abuse of ADHD meds grows with scrips

Scrips for ADHD meds have been growing at a rapid clip--and so has their abuse. From 1998 to 2005, the rate of scrips for these meds increased by about 80 percent, and over the same period their abuse increased by 76 percent, researchers found. Report

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.